ebola
virus
ebov
envelop
negativesens
rna
filovirus
caus
sever
hemorrhag
fever
human
nonhuman
primat
nhp
mouseadapt
ebov
caus
similar
acut
diseas
mice
offer
use
anim
model
studi
ebov
infect
ebov
infect
character
rapid
viral
replic
dysregul
innat
adapt
immun
respons
diseas
follow
profound
suppress
type
ifn
signal
contrast
excess
inflamm
lead
mucos
hemorrhag
multiorgan
failur
resembl
septic
shock
syndrom
viral
encod
antiifn
protein
play
major
role
ebov
virul
block
type
ifn
induct
dendrit
cell
dc
macrophag
act
virul
factor
necessari
recombin
viru
attain
infect
host
hand
block
ifn
signal
interf
ifn
activ
jakstat
pathway
line
evid
support
critic
import
type
ifn
signal
provid
resist
ebov
infect
mice
defici
transcript
factor
requir
ifn
induct
encod
membran
receptor
type
ifn
suscept
wild
type
zair
ebov
wild
type
mice
resist
studi
sudan
ebov
infect
human
show
level
significantli
higher
surviv
patient
fatal
ebov
infect
higher
level
proinflammatori
cytokineschemokin
high
product
report
correl
increas
resist
ebov
mice
well
administr
recombin
confer
delay
timetodeath
nhp
furthermor
use
adjunct
therapi
monoclon
antibodi
treatment
shown
enhanc
protect
nhp
ebov
infect
remain
potenti
threat
public
health
compound
lack
effect
prevent
treatment
overcom
problem
variou
vaccin
candid
develop
includ
variou
dna
construct
recombin
virus
vlp
well
treatment
antisens
sirna
vlp
subunitbas
vaccin
extens
studi
varieti
infecti
pathogen
vlp
prepar
ebov
filovirus
compos
matrix
protein
glycoprotein
gp
time
nucleoprotein
np
repres
potenti
promis
candid
ebov
vaccin
ebov
vlp
shown
confer
protect
upon
rodent
nhp
given
prior
infect
accompani
paper
show
postexposur
administr
trival
vlp
protect
mice
lethal
ebov
infect
credit
potenti
vlp
possibl
vaccin
studi
show
vlp
protect
requir
macrophag
dendrit
cell
dc
well
b
either
lymphocyt
indic
innat
adapt
immun
involv
confer
protect
aim
studi
investig
molecular
base
postexposur
protect
vlp
base
previou
report
vlp
stimul
type
ifn
express
dc
macrophag
vitro
focus
role
type
ifn
signal
found
postexposur
vlp
treatment
lead
acceler
activ
ifn
signal
result
earli
induct
isg
significantli
vlp
stimul
isg
induct
coincid
attenu
proinflammatori
cytokin
surg
ebov
infect
mice
reduc
inflammatori
respons
attribut
activ
type
ifn
signal
sinc
vlp
treat
ifnar
mice
unabl
inhibit
viral
replic
proinflammatori
respons
succumb
death
result
indic
earli
type
ifn
respons
major
mechan
contribut
vlp
mediat
protect
ebov
infect
ifnar
ifnar
mice
balbc
background
mice
background
bred
nichd
anim
facil
transfer
facil
unit
state
armi
medic
research
institut
infecti
diseas
usamriid
ebov
infect
studi
research
conduct
complianc
anim
welfar
act
feder
statut
regul
relat
anim
experi
involv
anim
adher
principl
state
guid
care
use
laboratori
anim
nation
research
council
facil
research
conduct
fulli
accredit
associ
assess
accredit
laboratori
anim
care
intern
iacuc
committe
approv
protocol
unit
state
armi
medic
research
institut
infecti
diseas
usamriid
iacuc
anim
monitor
least
daili
statu
evalu
accord
intervent
score
sheet
approv
usamriid
iacuc
monitor
increas
three
time
daili
anim
given
score
three
four
euthan
inhal
follow
confirmatori
cervic
disloc
analges
anesthet
use
studi
anim
euthan
human
purpos
reach
score
five
would
indic
anim
exhibit
ruffl
fur
weak
unrespons
andor
difficulti
walk
otherwis
anim
euthan
end
studi
vlp
compos
ebov
gp
np
gener
mammalian
cell
report
previous
vlp
prepar
use
studi
contain
endotoxin
umg
mice
infect
pfu
mouseadapt
ebov
via
intraperiton
ip
rout
mice
inject
vlp
dilut
pb
ip
h
ebov
infect
morbid
mortal
ebov
infect
mice
monitor
twice
daili
day
total
rna
liver
spleen
ebov
infect
mice
extract
trizol
method
invitrogen
cdna
synthes
total
rna
superscript
ii
revers
transcriptas
invitrogen
qpcr
amplif
done
ng
cdna
sybr
green
pcr
master
mix
appli
biosystem
revers
forward
primer
use
abi
prism
sequenc
detect
system
appli
biosystem
mrna
express
indic
gene
analyz
describ
detail
elsewher
primer
pair
use
ebov
gp
gene
primer
sequenc
follow
previou
public
transcript
level
normal
hprt
express
rel
express
statist
analysi
carri
excel
softwar
use
twotail
pair
student
test
data
repres
mean
least
three
independ
assay
sem
p
valu
consid
signific
assess
role
type
ifn
signal
vlpmediat
protect
ebov
infect
test
mice
protect
vlp
fig
wild
type
wt
mice
balbc
background
n
inject
vlp
infect
mous
adapt
ebov
morbid
mortal
check
daili
subsequ
day
wt
mice
without
vlp
inject
die
day
day
wherea
mice
receiv
vlp
surviv
ebov
infect
confirm
vlp
protect
mice
even
given
postinfect
contrast
ifnar
mice
receiv
vlp
die
day
without
vlp
inject
fig
result
agreement
previou
report
earli
death
maebov
infect
ifnar
mice
ebov
thought
initi
infect
dc
macrophag
liver
spleen
make
tissu
major
site
ebov
replic
mous
although
viru
infect
mani
organ
later
ascertain
whether
vlp
inhibit
viral
replic
measur
ebov
glycoprotein
gp
mrna
express
liver
spleen
wt
ifnar
mice
without
vlp
administr
qrtpcr
analysi
fig
found
level
gp
mrna
rose
sharpli
ifnar
mice
day
infect
gp
mrna
still
background
wt
mice
ifnar
mice
receiv
vlp
also
express
consider
amount
gp
mrna
although
level
vari
liver
spleen
vlp
treat
group
thu
ebov
appear
replic
faster
greater
extent
ifnar
mice
wt
mice
note
wt
mice
gp
mrna
level
began
increas
rapidli
day
peak
day
day
vlp
inject
inhibit
gp
mrna
express
half
fig
result
line
result
ifnar
mice
suscept
ebov
infect
suggest
possibl
vlp
mediat
protect
link
activ
type
ifn
signal
howev
vlp
inject
may
prevent
ebov
pathogenesi
ifnar
mice
possibl
diseas
manifest
sever
mice
wt
mice
hand
recent
shown
adenoviru
base
vaccin
protect
ifnar
mice
lethal
evob
infect
presum
antibodi
respons
indic
ifnar
mice
univers
vulner
antiebov
resist
attain
case
recent
report
ebov
vlp
activ
type
ifn
transcript
dc
macrophag
vitro
lead
induct
mani
isg
cell
ask
whether
vlp
stimul
isg
induct
vivo
wt
mice
infect
ebov
receiv
vlp
h
later
induct
isg
mrna
test
day
isg
encod
antivir
protein
first
examin
may
provid
earli
protect
ebov
infect
upper
panel
fig
compar
induct
antivir
isg
without
vlp
inject
liver
spleen
earli
stage
level
isg
consist
higher
vlpinject
group
without
vlp
later
stage
infect
howev
situat
revers
mice
without
vlp
higher
level
isg
seen
day
fig
complet
kinet
result
indic
vlp
administr
acceler
type
ifn
isg
induct
presum
provid
earli
antivir
activ
afford
without
vlp
next
test
whether
vlp
induc
isg
particularli
neg
regulatori
activ
question
interest
us
sinc
mice
receiv
vlp
express
higher
level
proinflammatori
cytokin
chemokin
rais
possibl
ifn
signal
exert
neg
regulatori
activ
toward
proinflammatori
respons
perhap
control
activ
shown
lower
panel
fig
induct
ifn
induc
gtpase
inhibit
lp
induc
endotoxin
shock
mice
deconjug
factor
neg
regul
tlr
signal
result
cytokin
induct
member
tripartit
motif
famili
downregul
tlr
induc
inflammatori
respons
express
isg
also
higher
vlp
inject
group
without
vlp
liver
spleen
similar
antivir
isg
express
neg
regulatori
factor
chang
later
stage
fig
data
indic
vlp
acceler
induct
antivir
neg
regulatori
isg
may
help
suppress
ebov
antiifn
antagon
see
discuss
confirm
vlp
induct
isg
depend
type
ifn
signal
next
test
isg
induct
ifnar
mice
expect
none
isg
test
fig
induc
ifnar
mice
vlp
treatment
ebov
infect
fig
ebov
pathophysiolog
sever
hemorrhag
symptom
tissu
damag
thought
associ
dysregul
inflammatori
cytokin
product
given
vlp
acceler
induct
neg
regulatori
isg
next
evalu
whether
vlp
modul
express
proinflammatori
gene
fig
express
chemokin
kc
inflammasom
gene
measur
ebov
infect
mice
without
vlp
gene
strongli
induc
upon
ebov
infect
peak
day
gradual
declin
day
case
express
significantli
attenu
vlptreat
group
compar
group
without
vlp
differ
dramat
earli
stage
day
express
reduc
least
agreement
result
note
serum
level
proinflammatori
cytokin
higher
ebov
infect
mice
treat
vlp
compar
without
vlp
result
support
view
limit
superflu
inflammatori
respons
contribut
vlp
mediat
protect
increas
evid
indic
type
ifn
antagon
inflammatori
respons
varieti
set
light
result
vlp
stimul
isg
known
suppress
proinflammatori
respons
import
determin
whether
type
ifn
signal
affect
ebov
induct
proinflammatori
cytokin
chemokin
result
fig
fig
compar
express
proinflammatori
factor
ifnar
ifnar
mice
infect
ebov
cytokin
chemokin
test
induc
ebov
infect
strain
importantli
level
much
higher
ifnar
mice
ifnar
mice
result
indic
type
ifn
signal
downregul
ebov
stimul
induct
proinflammatori
factor
possibl
isg
neg
regulatori
activ
result
indic
type
ifn
attenu
proinflammatori
respons
ebov
infect
explor
whether
type
ifn
similar
activ
set
ebov
infect
next
test
lp
induc
inflammatori
respons
macrophag
vitro
lp
activ
mediat
proinflammatori
cytokin
induct
result
endotoxin
shock
shown
fig
combin
treatment
lp
led
hyper
induct
chemokin
kc
ifnar
macrophag
compar
wt
cell
lp
also
induc
neg
feedback
factor
much
lower
express
ifnar
cell
ifnar
cell
result
support
model
type
ifn
neg
regul
proinflammatori
cytokinechemokin
respons
least
situat
found
hyperinduc
ifnar
cell
suggest
proinflammatori
gene
regul
type
ifn
factor
data
shown
altern
differ
may
reflect
varianc
vivo
vitro
condit
defin
pathway
downstream
ifnar
activ
import
vlp
protect
direct
attent
transcript
factor
express
macrophag
dc
induc
ifn
tlr
ligand
depend
manner
play
pivot
role
facilit
innat
immun
respons
although
involv
initi
trigger
type
ifn
induct
amplifi
ifn
transcript
dc
macrophag
promot
induct
multipl
antimicrobi
factor
requir
innat
resist
varieti
pathogen
stimul
express
mhc
costimulatori
molecul
boost
antigen
present
thu
test
whether
disrupt
affect
vlpmediat
protect
ebov
surviv
data
fig
show
approxim
mice
receiv
vlp
die
day
nearli
ident
mortal
curv
wt
mice
without
vlp
expect
major
wt
mice
receiv
vlp
surviv
ebov
infect
note
ifnar
mice
die
day
earlier
mice
may
attribut
differ
mous
background
correl
lack
protect
ebola
gp
mrna
level
much
higher
ebov
infect
mice
mice
without
vlp
fig
next
examin
whether
induct
antivir
neg
feedback
isg
depend
data
fig
illustr
induct
isg
meager
mice
contrast
robust
induct
mice
importantli
vlp
rescu
isg
induct
mice
result
similar
liver
spleen
fig
fig
result
indic
vlp
upon
initi
activ
type
ifn
cascad
reli
subsequ
activ
downstream
pathway
repres
confer
protect
ebov
gain
insight
pathway
vlp
confer
resist
ebov
infect
investig
role
type
ifn
signal
vivo
found
significantli
contribut
vlpmediat
protect
conclus
support
observ
postexposur
vlp
treatment
acceler
isg
induct
ebov
infect
mice
lead
reduc
viral
replic
inflammatori
gene
express
support
critic
role
type
ifn
signal
protect
vlp
induc
isg
ifnar
mice
protect
mice
lethal
ebov
infect
result
consist
report
postexposur
treatment
increas
protect
ebov
infect
nhp
like
vlp
initi
stimul
type
ifn
gene
turn
led
earli
induct
isg
line
notion
recent
show
exogen
vlp
stimul
transcript
dc
macrophag
vitro
event
coupl
immedi
robust
isg
induct
may
reason
assum
ifnar
mice
protect
vlp
primarili
isg
induct
absent
howev
ifnar
mice
may
suscept
infect
due
addit
defect
innat
immun
secondari
consequ
defect
ifn
signal
obliter
vlp
protect
contour
notion
howev
note
ifnar
mice
protect
ebov
adenovirusbas
vaccin
indic
ifnar
mice
total
without
defens
rather
possibl
ifnar
mice
protect
vlp
reli
isg
induct
protect
wherea
protect
adenoviru
vaccin
depend
antibodi
respons
vlpinduc
isg
includ
antivir
protein
known
inhibit
replic
rna
virus
well
neg
feedback
factor
curb
excess
inflammatori
respons
although
question
antivir
isg
effect
inhibit
ebov
replic
await
research
anticip
antivir
isg
induc
vlp
may
interfer
ebov
life
cycl
signific
acceler
ifn
respons
vlp
mediat
protect
avail
evid
suggest
vlp
may
overcom
ebov
antiifn
antagon
viral
encod
disabl
entir
ifn
system
host
block
jakstat
pathway
ifn
signal
ebov
virul
factor
inhibit
type
ifn
induct
mani
cell
type
previous
show
inhibit
type
ifn
induct
murin
dc
prematur
sumoyl
inactiv
thought
decis
effect
subsequ
host
resist
sinc
abat
ifn
signal
would
impair
proper
innat
immun
respons
lead
defici
dc
matur
defect
antigen
present
aberr
inflamm
compromis
innat
immun
would
consequ
undermin
develop
adapt
immun
see
model
fig
remark
vlp
treat
mice
isg
induct
began
earli
within
day
ebov
infect
day
vlp
treatment
littl
isg
induct
seen
mice
without
vlp
delay
isg
induct
ebov
infect
mice
reminisc
report
show
influenza
viru
delay
isg
induct
lung
epitheli
cell
influenza
antiifn
protein
link
diseas
patholog
influenza
viru
strain
defici
shown
induc
isg
earlier
wild
type
viru
although
wild
type
strain
stimul
isg
later
support
view
viral
antiifn
factor
stall
isg
induct
rather
complet
abrog
induct
also
observ
isg
induct
day
later
mice
without
vlp
may
envisag
vlp
trigger
ifn
activ
earli
therebi
elud
activ
ebov
antiifn
protein
model
fig
strike
observ
made
studi
vlpdepend
suppress
proinflammatori
respons
suppress
result
type
ifn
signal
ifnar
mice
express
higher
level
proinflammatori
cytokin
chemokin
observ
ebov
infect
also
lp
stimul
result
accord
grow
recognit
type
ifn
link
attenu
inflammatori
respons
exampl
pinto
et
al
report
west
nile
viru
infect
model
ifnar
mice
express
excess
proinflammatori
cytokin
includ
found
studi
compar
wt
mice
correl
increas
diseas
patholog
system
overt
inflammatori
respons
attribut
ifn
signal
macrophag
dc
induct
proinflammatori
cytokin
chemokin
may
neg
regul
ifn
signal
seri
neg
feedback
factor
induc
ifn
signal
restrict
lp
induc
endotoxin
shock
without
limit
express
inhibit
proinflammatori
cytokin
induct
least
part
interf
depend
arm
transcript
addit
factor
may
act
posttranscript
mechan
affect
inflammasom
activ
regard
guarda
et
al
report
type
ifn
inhibit
product
inhibit
activ
inflammasom
induct
thu
isg
neg
regulatori
activ
may
preferenti
attenu
proinflammatori
pathway
spare
ifn
induct
pathway
given
earlier
observ
grossli
affect
activ
strongli
inhibit
type
ifn
activ
ebov
may
promot
proinflammatori
pathway
least
part
lastli
show
transcript
factor
requir
vlp
mediat
postexposur
protect
result
offer
ad
mechanist
insight
pathway
vlp
provid
protect
express
predominantli
macrophag
dc
help
amplifi
type
ifn
gene
induct
boost
ifn
biolog
activ
given
macrophag
dc
put
earli
site
ebov
infect
vlp
may
exert
major
impact
cell
facilit
earli
innat
immun
depend
manner
conclus
vlp
confer
postexposur
protect
upon
ebov
infect
mice
rapidli
induc
isg
therebi
permit
time
establish
antivir
antiinflammatori
state
host
vlp
may
act
primarili
reliev
ebov
antagon
type
ifn
result
reduc
system
inflamm
subsequ
enhanc
acquir
immun
respons
model
fig
